1. ETMR: a tumor entity in its infancy

   • Sander Lambo
   • Katja von Hoff
   • Marcel Kool

   Review Open access 29 June 2020 Pages: 249 - 266

   

2. Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

   • Juan Lantero Rodriguez
   • Thomas K. Karikari
   • Nicholas J. Ashton

   Original Paper Open access 27 July 2020 Pages: 267 - 278

   

3. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ

   • Arne Ittner
   • Prita Riana Asih
   • Lars M. Ittner

   Original Paper 29 July 2020 Pages: 279 - 294

   

4. miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease

   • Ben Readhead
   • Jean-Vianney Haure-Mirande
   • Michelle E. Ehrlich

   Original Paper 14 July 2020 Pages: 295 - 315

   

5. SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease

   • Neelam Younas
   • Saima Zafar
   • Inga Zerr

   Original Paper Open access 23 June 2020 Pages: 317 - 339

   

6. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease

   • S. Bandres-Ciga
   • S. Saez-Atienzar
   • the International Parkinson Disease Genomics Consortium

   Original Paper Open access 29 June 2020 Pages: 341 - 358

   

7. Lesion stage-dependent causes for impaired remyelination in MS

   • Katharina Heß
   • Laura Starost
   • Tanja Kuhlmann

   Original Paper Open access 24 July 2020 Pages: 359 - 375

   

8. The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment

   • Yan Ting Liu
   • Fang Liu
   • Zhe Bao Wu

   Original Paper 22 June 2020 Pages: 377 - 396

   

9. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19

   • Zane Jaunmuktane
   • Ula Mahadeva
   • Sebastian Brandner

   Correspondence Open access 08 July 2020 Pages: 397 - 400

   

10. ATP10B and the risk for Parkinson’s disease

    • Raquel Real
    • Anni Moore
    • the International Parkinson’s Disease Genomics Consortium (IPDGC)

    Correspondence 15 June 2020 Pages: 401 - 402

11. Reply: ATP10B and the risk for Parkinson’s disease

    • Stefanie Smolders
    • Christine Van Broeckhoven

    Correspondence 15 June 2020 Pages: 403 - 404

12. CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort

    • Stephanie T. Jünger
    • Felipe Andreiuolo
    • Torsten Pietsch

    Correspondence Open access 08 June 2020 Pages: 405 - 407

    

13. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

    • Philipp Sievers
    • Thomas Hielscher
    • Felix Sahm

    Correspondence Open access 08 July 2020 Pages: 409 - 413

    

14. Correction to: Somatic mutations in neurons during aging and neurodegeneration

    • Bert M. Verheijen
    • Marc Vermulst
    • Fred W. van Leeuwen

    Correction Open access 06 July 2020 Pages: 415 - 415